<DOC>
	<DOCNO>NCT01052012</DOCNO>
	<brief_summary>This research study test SABER™-Bupivacaine ( experimental pain-relieving medication ) . SABER™-Bupivacaine design continuously deliver bupivacaine , common local anesthetic , day order treat local post-surgical pain . The purpose study investigate safety ( side effect ) associate use SABER™-Bupivacaine well work reduce pain opioid-related side effect follow various kind abdominal surgery .</brief_summary>
	<brief_title>Bupivacaine Effectiveness Safety SABER™ Trial</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Patients must able read understand consent form , provide write consent , complete trialrelated procedure , communicate trial staff Males female , 18 year age old schedule undergo elective general abdominal surgery Patients must healthy mild systemic diseasePatients must healthy mild systemic disease BMI &lt; 45 Patients must ECG wave form within normal limit Female male patient must agree use medically acceptable method contraception throughout entire trial period 1 week trial participation complete Patients pregnant lactate Patients undergo emergency surgery ( unless full consent obtain screening procedure complete prior surgery ) Significant concomitant surgical procedure History multiple prior laparotomy procedure Cancer know metastasis preoperatively , suspect impact postoperative recovery pain Planned formation stoma surgery plan undergo another laparotomy procedure within 30 day postoperatively Preoperative evidence sepsis septic shock Preoperative evaluation suggest surgery may preclude full closure incision ( ) Patients current regular use systemic steroid , anticonvulsant , antiepileptic , antidepressant , monoamine oxidase inhibitor , withdrawn medication Patients current regular use drug know significantly prolong QTc interval Patients know hypersensitivity local anesthetic agent amide type ( e.g . lidocaine , bupivacaine ) Patients known hypersensitivity morphine Patients condition contraindicate use opioids Patients atrial fibrillation/flutter nonsinus rhythm ( include pace rhythm ) ; leave bundle branch block ( LBBB ) ; follow condition : right bundle branch block ( RBBB ) presence cardiac disease , significant cardiomyopathy , myocardial infarction within last 6 month Patients serum creatinine level two time local laboratory normal limit Patients receive great 600 mg morphine equivalent daily dose three day per week month prior surgical procedure Patients currently treat methadone , history methadone use within previous 6 month Patients know suspected abuse opioids illicit drug Patients know suspected alcohol abuse Participation another clinical trial time within 30 day trial Patients , Investigator 's opinion , participate trial may capable follow trial schedule reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Postoperative pain</keyword>
	<keyword>Post-operative pain</keyword>
	<keyword>Opioid</keyword>
	<keyword>Laparoscopic surgery</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Local anesthetic</keyword>
</DOC>